NCT00481754View on ClinicalTrials.gov

Benign Reproductive Tissue Analysis for Endometrial Cancer Markers

CompletedOBSERVATIONAL
Enrollment

359

Participants

Timeline

Start Date

April 24, 2006

Primary Completion Date

November 13, 2020

Study Completion Date

November 13, 2020

Conditions
Oophorectomy for Benign ReasonsHysterectomy
Trial Locations (1)

15213

Magee Women's hospital, Pittsburgh

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00481754 - Benign Reproductive Tissue Analysis for Endometrial Cancer Markers | Biotech Hunter | Biotech Hunter